Invasive Staphylococcus aureus infections are common, causing high mortality,
compounded by the propensity of the bacterium to develop drug resistance. S. aureus is an …

Due to the emerging bacterial resistance and the protection of tenacious biofilms, it is hard
for the single antibacterial modality to achieve satisfactory therapeutic effects nowadays. In …

Antimicrobial-resistant ESKAPE (E nterococcus faecium, S taphylococcus aureus, K
lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E …

Flavonoids are a category of plant-derived compounds which exhibit a large number of
health-related effects. One of the most well-known and studied flavonoids is kaempferol …

Infectious diseases are the second most important cause of human death worldwide;
Staphylococcus aureus (S. aureus) is a very common human pathogenic microorganism that …

In recent years, we have seen antimicrobial resistance rapidly emerge at a global scale and
spread from one country to the other faster than previously thought. Superbugs and …

Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

The infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is a global
threat to public health. Vancomycin remains one of the first-line drugs for the treatment of …

Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …

The evolution of Staphylococcus aureus during the modern antibiotic era has been
delineated by distinct strain emergence events, many of which include acquisition of …